RxDoctor Payments Data

Robert Cohen

Foot & Ankle Surgery · Paoli, PANPI 1023095494

Payments from drug & device makers

$658in general payments, 2019–2025

Across 23 payments — averaging $28.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$151
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$112
  • Paratek Pharmaceuticals, Inc.$84
  • Nevro Corp.$52
  • Smith+Nephew$47
  • Integra Lifesciences Corporation$42
  • plus $170 from 9 others

What the payments were for

  • Food & beverage$658100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$658 in reported general payments places this provider in the 25th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$331,489
Medicare patients
882
Services billed
4,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole12$8,833
Ketoconazole215$5,004
Mupirocin147$1,104
Gentamicin Sulfate14$1,043
Nitro-BidNitroglycerin25$882
CiclopiroxCiclopirox Olamine30$795
Triamcinolone Acetonide68$381
Ciclopirox19$328
Cephalexin68$268
Terbinafine Hcl88$244
Gabapentin15$161
Levofloxacin16$124
Doxycycline Hyclate17$121
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$87

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia$112$8,83312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 575 foot & ankle surgery providers in Pennsylvania.

Other foot & ankle surgery in Paoli

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →